Botox sales soar 300 per cent
10 November 2008
According to a UK provider of botulinum toxin - or Botox - sales of the wrinkle-relaxing injections have soared 300 per cent in the last year.
First popular in the realms of celebrity culture, Botox has moved in bounds towards social acceptance, with thousands of Brits choosing to undergo the non-surgical procedure as part of their anti-aging beauty regime.
Botox use has increased heavily, even despite the current financial crisis - and so has dermal filler treatments, which have increased by 200 per cent since the same time in 2007.
Both non-surgical treatments are widely regarded as instant, cost-effective ways of achieving a quick fix for unsavoury facial and body features, such as wrinkles, scars and soft-tissue volume loss.
The procedures are frequently in the news as popular choices for celebrities hoping to retain their looks and are increasingly becoming more socially-accepted as procedures suitable for everybody, not just those constantly within the public eye.
The announcement follows last month's assurance from plastic surgeons that the cosmetic industry has largely been unaffected by the credit crunch, with just as many customers opting for breast augmentations and facelifts as ever before - however, the news was trailed by admissions that large surgical procedures had seen a drop only two weeks later.
As non-surgical procedures, like wrinkle-relaxing injections, dermal fillers and chemical peels are significantly less costly than surgical treatments, it is unsurprising that more and more consumers are choosing them as a temporary solution while their finances are unstable. The quick result offered by these treatments and little recovery time also aids their popularity.